News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78,364 Results
Type
Article (972)
Company Profile (12)
Press Release (77380)
Section
Business (21252)
Career Advice (129)
Deals (8320)
Drug Development (6712)
Employer Resources (2)
FDA (1326)
Job Trends (1561)
News (38130)
Policy (2766)
Tag
Academia (88)
Accelerated approval (3)
Allergies (2)
Alliances (5937)
ALS (11)
Alzheimer's disease (161)
Antibody-drug conjugate (ADC) (19)
Approvals (1384)
Artificial intelligence (26)
Autoimmune disease (7)
Automation (3)
Bankruptcy (84)
Best Places to Work (1392)
Biosimilars (29)
Biotechnology (9)
Bladder cancer (9)
Brain cancer (11)
Breast cancer (53)
Cancer (477)
Cardiovascular disease (23)
Career advice (110)
CAR-T (20)
Celiac Disease (1)
Cell therapy (56)
Cervical cancer (3)
Clinical research (6052)
Collaboration (120)
Compensation (58)
Complete response letters (4)
COVID-19 (104)
CRISPR (1)
C-suite (71)
Cystic fibrosis (11)
Data (617)
Depression (10)
Diabetes (31)
Diagnostics (729)
Digital health (5)
Diversity, equity & inclusion (1)
Drug discovery (17)
Drug pricing (5)
Duchenne muscular dystrophy (12)
Earnings (7860)
Employer branding (1)
Employer resources (2)
Events (10825)
Executive appointments (127)
FDA (1625)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (164)
Gene editing (6)
Gene therapy (12)
GLP-1 (29)
Government (192)
Guidances (46)
Healthcare (2000)
IgA nephropathy (2)
Immunology and inflammation (10)
Immuno-oncology (7)
Indications (10)
Infectious disease (119)
Inflammatory bowel disease (28)
Influenza (9)
Intellectual property (42)
Interviews (23)
IPO (4919)
Job creations (208)
Job search strategy (93)
JPM (1)
Layoffs (8)
Legal (904)
Liver cancer (4)
Lung cancer (64)
Lymphoma (26)
Machine learning (2)
Manufacturing (46)
MASH (13)
Medical device (1874)
Medtech (1878)
Mergers & acquisitions (3842)
Metabolic disorders (73)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (20)
Neuropsychiatric disorders (5)
Neuroscience (282)
NextGen: Class of 2026 (905)
Non-profit (167)
Obesity (30)
Opinion (3)
Ovarian cancer (18)
Pain (22)
Pancreatic cancer (49)
Parkinson's disease (39)
Partnered (3)
Patents (80)
Patient recruitment (41)
Peanut (2)
People (6739)
Pharmacy benefit managers (3)
Phase 1 (1876)
Phase 2 (2808)
Phase 3 (1965)
Pipeline (569)
Policy (2)
Postmarket research (146)
Preclinical (733)
Press Release (1)
Prostate cancer (19)
Psychedelics (2)
Radiopharmaceuticals (48)
Rare diseases (56)
Real estate (528)
Recruiting (1)
Regulatory (2065)
Reports (6)
Research institute (140)
Resumes & cover letters (15)
RSV (6)
Schizophrenia (33)
Series A (21)
Series B (19)
Sickle cell disease (16)
Spinal muscular atrophy (3)
Startups (497)
State (1)
Stomach cancer (1)
Supply chain (8)
Vaccines (37)
Weight loss (5)
Women's health (5)
Date
Last 7 days (61)
Last 30 days (212)
Last 365 days (3481)
2026 (294)
2025 (3545)
2024 (4453)
2023 (5504)
2022 (6721)
2021 (7851)
2020 (7553)
2019 (5271)
2018 (4083)
2017 (3918)
2016 (3233)
2015 (4529)
2014 (3094)
2013 (2533)
2012 (2710)
2011 (2362)
2010 (2113)
Location
Africa (22)
Alabama (6)
Arizona (44)
Arkansas (1)
Asia (3786)
Australia (504)
California (1389)
Canada (230)
China (64)
Colorado (41)
Connecticut (81)
Delaware (30)
Europe (5531)
Florida (278)
Georgia (37)
Idaho (7)
Illinois (99)
India (2)
Indiana (85)
Japan (25)
Kansas (19)
Kentucky (7)
Louisiana (3)
Maine (45)
Maryland (176)
Massachusetts (850)
Michigan (72)
Minnesota (76)
Mississippi (4)
Missouri (19)
Montana (2)
Nebraska (4)
Nevada (38)
New Hampshire (14)
New Jersey (431)
New Mexico (2)
New York (440)
North Carolina (284)
Northern California (557)
Ohio (41)
Oregon (3)
Pennsylvania (345)
Rhode Island (4)
South America (65)
South Carolina (11)
Southern California (624)
Tennessee (45)
Texas (374)
United States (5415)
Utah (62)
Vermont (1)
Virginia (46)
Washington D.C. (2)
Washington State (89)
West Virginia (1)
Wisconsin (23)
78,364 Results for "cerevasc llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CereVasc Completes Enrollment of ETCHES Study of the eShunt® System for the Treatment of Communicating Hydrocephalus
January 22, 2026
·
3 min read
Press Releases
CereVasc Receives Health Canada Investigational Testing Authorization for STRIDE Clinical Trial of the eShunt® System
June 19, 2025
·
3 min read
Press Releases
CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric Patients
April 23, 2025
·
4 min read
Genetown
CereVasc Receives FDA IDE Approval for the STRIDE Pivotal Study of the eShunt System for Treatment of Normal Pressure Hydrocephalus
CereVasc, Inc. announced today that it has received approval from the US Food and Drug Administration (FDA) to initiate its “Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus” (STRIDE trial).
May 7, 2024
·
2 min read
Press Releases
CereVasc Announces First Patient Randomized to eShunt® System Treatment in STRIDE Pivotal Trial
February 25, 2025
·
3 min read
Genetown
CereVasc’s eShunt® System Study Data Presented at the ABC WIN Seminar
CereVasc, Inc. announced that data from its clinical studies in the United States and Argentina, examining the use of its eShunt System to treat communicating hydrocephalus, was presented at the ABC WIN Seminar in Val d’Isere.
January 23, 2024
·
2 min read
Genetown
CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced it has successfully completed the initial closing of a $70 Million Series B financing.
May 13, 2024
·
2 min read
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Press Releases
CereVasc Announces First Enrollment in STRIDE Clinical Trial of the eShunt® System for Normal Pressure Hydrocephalus
January 14, 2025
·
3 min read
Press Releases
CereVasc to Present at the Piper Sandler 36th Annual Healthcare Conference
November 25, 2024
·
1 min read
1 of 7,837
Next
